Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Dose of Acetylsalicylic Acid After Coronary Artery Bypass Grafting

NCT02482857 is registered in ClinicalTrials.gov with Karolinska University Hospital as lead sponsor.

NCT NCT02482857
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02482857 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Dose of Acetylsalicylic Acid After Coronary Artery Bypass Grafting
Lead sponsor
Karolinska University Hospital
Phase
Phase 2/3
Overall status
Completed
Start date
December 31, 2011
Completion date
July 31, 2015
Enrollment
45 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery bypass surgery, stable angina